ONKI3 | Medical Subject Headings

The ONKI is provided as a part of the ONKI Living Lab - an open lab for testing the latest semantic web technologies in practice, with real users like you. Currently, over 10 000 people are using ONKI each month.

We hope you like the ONKI service and enjoy using it for your purposes!

If you encounter any problems or have improvement ideas, please contact the ONKI team. We are also very much interested in your success stories in using ONKI - please share your experiences!

The ONKI Team

Jouni Tuominen, Living Lab contact person, APIs, widgets, publishing of ontologies, etc.
Eero Hyvönen, professor, head of research group

Former members: Kim Viljanen, Rami Alatalo.

Building the future of the Semantic Web and beyond.

SeCo's homepage
For the latest semantic news, follow us on Twitter and fan us on Facebook!

How can we help you?

Live presentations about ONKI: what it is? how to use it?
Support for creating and publishing ontologies.
Online technical support for using ONKI.
Co-operation in projects.
And more, please ask.

suomeksi på svenska in English

The way property values are displayed: value/row values side by side

The way concept relations are shown: separately in hierarchy

Myeloablative Agonists

Loading results...


Hierarchy:	Medical Subject Headings (MeSH) ∟ Chemical Actions and Uses ∟ Pharmacologic Actions ∟ Physiological Effects of Drugs ∟ Immunologic Factors ∟ Immunosuppressive Agents ∟ Myeloablative Agonists 9 coordinate concepts ∟ Angiogenesis Inhibitors \| ∟ Antibiotics, Antineoplastic \| ∟ Anticarcinogenic Agents \| ∟ Antimetabolites, Antineoplastic \| ∟ Antimitotic Agents \| ∟ Antineoplastic Agents, Alkylating \| ∟ Antineoplastic Agents, Hormonal \| ∟ Antineoplastic Agents, Phytogenic \| ∟ Complement Inactivating Agents Medical Subject Headings (MeSH) ∟ Chemical Actions and Uses ∟ Pharmacologic Actions ∟ Therapeutic Uses ∟ Antineoplastic Agents ∟ Myeloablative Agonists 9 coordinate concepts ∟ Angiogenesis Inhibitors \| ∟ Antibiotics, Antineoplastic \| ∟ Anticarcinogenic Agents \| ∟ Antimetabolites, Antineoplastic \| ∟ Antimitotic Agents \| ∟ Antineoplastic Agents, Alkylating \| ∟ Antineoplastic Agents, Hormonal \| ∟ Antineoplastic Agents, Phytogenic \| ∟ Complement Inactivating Agents X
Broader terms:	Medical Subject Headings (MeSH) ∟ Chemical Actions and Uses ∟ Pharmacologic Actions ∟ Physiological Effects of Drugs ∟ Immunologic Factors ∟ Immunosuppressive Agents ∟ Myeloablative Agonists Medical Subject Headings (MeSH) ∟ Chemical Actions and Uses ∟ Pharmacologic Actions ∟ Therapeutic Uses ∟ Antineoplastic Agents ∟ Myeloablative Agonists Immunosuppressive Agents > Immunologic Factors > Physiological Effects of Drugs > Pharmacologic Actions > Chemical Actions and Uses > Medical Subject Headings (MeSH) Antineoplastic Agents > Therapeutic Uses > Pharmacologic Actions > Chemical Actions and Uses > Medical Subject Headings (MeSH) X
Annotation:	DF: MYELOABLATIVE AG X
historyNote*:	98 X
publicMeSHNote*:	98 X
Scope note:	Agents that destroy bone marrow activity. They are used to prepare patients for BONE MARROW TRANSPLANTATION or STEM CELL TRANSPLANTATION. X
activeMeSHYear*:	2006 \| 2007X
dateCreated*:	1997-06-20X
dateEstablished*:	1998-01-01X
dateRevised*:	2005-06-30X
recordAuthorizer*:	sjnX
recordMaintainer*:	ssbX
recordOriginator*:	AGSX
Type:	Concept X
Coordinate terms:	Angiogenesis Inhibitors \| Antibiotics, Antineoplastic \| Anticarcinogenic Agents \| Antimetabolites, Antineoplastic \| Antimitotic Agents \| Antineoplastic Agents, Alkylating \| Antineoplastic Agents, Hormonal \| Antineoplastic Agents, Phytogenic \| Complement Inactivating Agents X
URI:	X
Labels and equivalent concepts:	Myeloablatiiviset agonistit (fi) Myeloablatiivinen agonisti (fi, replaced) Luuydintä tuhoavat aineet (fi, replaced) Luuydintä tuhoava aine (fi, replaced) Myeloablativa stimulerare (sv) Myeloablativa agonister (sv, replaced) Myeloablative Agonist (en, replaced) X
Share:	X